Giannarelli, Diana
 Distribuzione geografica
Continente #
AS - Asia 2.072
NA - Nord America 1.597
EU - Europa 1.192
SA - Sud America 547
AF - Africa 56
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.476
Nazione #
US - Stati Uniti d'America 1.501
SG - Singapore 782
IT - Italia 479
CN - Cina 456
BR - Brasile 449
VN - Vietnam 356
DE - Germania 147
FR - Francia 130
IN - India 92
FI - Finlandia 85
HK - Hong Kong 83
GB - Regno Unito 76
JP - Giappone 73
SE - Svezia 53
AR - Argentina 44
CA - Canada 42
ID - Indonesia 39
IE - Irlanda 39
KR - Corea 39
ES - Italia 37
MX - Messico 35
NL - Olanda 35
BD - Bangladesh 33
RU - Federazione Russa 26
IQ - Iraq 22
EC - Ecuador 21
ZA - Sudafrica 20
AT - Austria 18
PL - Polonia 18
TR - Turchia 16
CO - Colombia 11
UZ - Uzbekistan 11
PH - Filippine 10
PK - Pakistan 10
MA - Marocco 9
BE - Belgio 8
SA - Arabia Saudita 7
UA - Ucraina 7
CZ - Repubblica Ceca 6
IL - Israele 6
KG - Kirghizistan 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
DO - Repubblica Dominicana 5
TN - Tunisia 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
LB - Libano 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PE - Perù 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
HU - Ungheria 2
IR - Iran 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
KW - Kuwait 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TO - Tonga 1
Totale 5.476
Città #
Singapore 432
San Jose 284
Rome 213
Ashburn 212
Hefei 123
Ho Chi Minh City 123
Hanoi 92
Beijing 85
New York 78
Los Angeles 74
Hong Kong 72
Tokyo 71
Milan 67
Lauterbourg 51
St Louis 51
Frankfurt am Main 49
Hyderabad 49
Helsinki 47
Munich 47
São Paulo 43
Dallas 39
The Dalles 39
Dublin 38
Seoul 38
Council Bluffs 33
Kent 32
Jakarta 26
Da Nang 24
Orem 24
Buffalo 21
Lappeenranta 20
Nuremberg 18
Turku 18
Chicago 17
Haiphong 17
Denver 16
Stockholm 16
Atlanta 15
Phoenix 15
London 14
Montreal 14
Rio de Janeiro 14
Castelvetrano 13
Düsseldorf 13
Guayaquil 13
Mexico City 13
Santa Clara 13
Brasília 12
Poplar 12
Porto Alegre 12
Warsaw 12
Ankara 11
Bexley 11
Boardman 11
Brooklyn 11
Johannesburg 11
Moscow 11
Tashkent 11
Vienna 11
Paris 10
Toronto 10
Amsterdam 9
Bari 9
Chennai 9
Florence 9
Maceió 9
Mumbai 9
North Bergen 9
Belo Horizonte 8
Campinas 8
Shanghai 8
Turin 8
Baghdad 7
Biên Hòa 7
Brussels 7
Bến Tre 7
Hải Dương 7
San Francisco 7
Bishkek 6
Boston 6
Buenos Aires 6
Cattolica 6
City of London 6
Dhaka 6
Fortaleza 6
Houston 6
Madrid 6
Manchester 6
Vancouver 6
Washington 6
Newark 5
Nha Trang 5
Olomouc 5
Salvador 5
Addis Ababa 4
Baku 4
Berlin 4
Charlotte 4
Concepción 4
Erbil 4
Totale 3.245
Nome #
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 163
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 152
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 148
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 140
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 140
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 137
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 136
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 135
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 133
Validation of Esaso Classification of Diabetic Maculopathy 131
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 125
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 124
Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) 122
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 122
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 122
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 121
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 119
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 115
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence 112
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer 112
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 109
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese) 109
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group 109
A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions: the MYometrial Lesion UltrasouNd And mRi study 109
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 108
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience 104
Flurbiprofen in the subglottic space to prevent postoperative sore throat after cardiac surgery: A randomized double-blind study 103
Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis 102
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 100
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 100
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 100
STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs 96
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer 93
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis 88
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program 87
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis 86
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 83
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy 80
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 80
Lymph node staging in grade 1–2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? 80
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 79
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 79
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 78
Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: clinical insights from a multicenter experience 78
The new surgical robot Hugo™ RAS for total hysterectomy: a pilot study 76
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 75
Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer 75
Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study 70
Protocol for an international multicenter, prospective, observational, non-competitive, study to validate and optimise prediction models of 90-day and 1-year allograft failure after liver transplantation: The global IMPROVEMENT Study 70
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 62
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 49
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 48
Secondary analyses from a randomized clinical trial: Age as the key prognostic factor in endometrial carcinoma 48
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study 47
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 37
Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm trial with stopping rules (ENGOT-cx23/MITO/LASH trial) 36
Microscopic assessment of lymph node status in gynecological malignancies using full-field optical coherence tomography 34
Totale 5.576
Categoria #
all - tutte 19.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202370 0 0 0 0 0 1 2 13 4 2 16 32
2023/2024373 9 48 51 23 21 53 26 7 7 25 53 50
2024/20251.297 25 10 53 46 58 45 66 37 95 169 370 323
2025/20263.836 411 240 326 618 541 195 594 250 271 271 119 0
Totale 5.576